European Commission Expects Generic Medicines Exempt from Latest U.S. Tariffs

The European Commission has stated that it expects European generic medicines to be excluded from the latest round of U.S. tariffs imposed by President Donald Trump. The Commission argues that Washington committed to a zero-tariff rate on these products under the transatlantic trade deal reached last year.

This interpretation suggests that trade negotiations have already addressed tariffs on pharmaceutical products, potentially shielding European generic drugmakers from new trade barriers. The announcement comes amid ongoing tensions over U.S. tariff policies and their impact on transatlantic commerce.